List of insiders holdings for DiaMedica Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | STAHLBERG JAN TRILL AB 10% Owner | 2026-02-06 16:33:54 | 8,825,742 0 | 8,825,742 | Form 13G |
| 2 | Von Koch Thomas TomEnterprise AB TomEnterprise Private AB 10% Owner | 2025-07-30 17:31:32 | 8,383,577 0 | 8,383,577 | Form 13G |
| 3 | JACINTO RICHARD II 10% Owner | 2025-11-07 17:30:12 | 4,958,823 0 | 4,958,823 | Form 13G |
| 4 | Xiao Zhenyu Hermeda Industrial Co. Ltd Director 10% Owner | 2020-12-23 16:31:17 | 936,805 0 | 936,805 | Form 13G |
| 5 | Xiao Zhenyu Director | 2020-12-23 16:31:17 | 936,805 0 | 936,805 | Form 13G |
| 6 | Wambeke David J. Chief Business Officer | 2025-06-03 16:19:13 | 777,114 0 | 777,114 | Form 4 |
| 7 | Pauls Dietrich John President & CEO | 2026-06-03 17:23:45 | 380,000 0 | 380,000 | Form 4 |
| 8 | Pilnik Richard D. Director | 2025-04-08 16:41:36 | 312,995 0 | 312,995 | Form 4 |
| 9 | Lorianne Masuoka K. Chief Medical Officer | 2024-01-23 16:23:11 | 285,000 0 | 285,000 | Form 4 |
| 10 | Kellen Scott CFO & Secretary | 2026-06-03 17:23:15 | 162,000 0 | 162,000 | Form 4 |
| 11 | Burroughs Amy L. Director | 2023-01-03 16:36:27 | 73,288 0 | 73,288 | Form 4 |
| 12 | Verdoorn Todd A. Chief Scientific Officer | 2019-06-26 16:54:07 | 73,025 0 | 73,025 | Form 4 |
| 13 | Krop Julie Chief Medical Officer | 2026-06-03 17:22:33 | 67,500 0 | 67,500 | Form 4 |
| 14 | Gruis Kirsten L Chief Medical Officer | 2023-06-02 16:55:43 | 67,000 0 | 67,000 | Form 4 |
| 15 | Daves Julie VanOrsdel SVP Clinical Development Oper. | 2023-06-02 17:16:33 | 54,000 0 | 54,000 | Form 4 |
| 16 | Parsons James T. Director | 2026-06-03 17:24:25 | 51,189 0 | 51,189 | Form 4 |
| 17 | ALCORN HARRY W JR SVP, Clinical Operations | 2021-09-15 16:37:42 | 43,582 399 | 43,981 | Form 4 |
| 18 | Semba Charles Pauling Director | 2026-06-03 17:26:24 | 40,412 0 | 40,412 | Form 4 |
| 19 | Lewis Tanya Director | 2026-06-03 17:26:55 | 40,412 0 | 40,412 | Form 4 |
| 20 | O'Connor Daniel J. Director | 2026-06-03 17:27:26 | 40,412 0 | 40,412 | Form 4 |
| 21 | Kuntz Richard Director | 2026-06-03 17:27:59 | 40,412 0 | 40,412 | Form 4 |
| 22 | Giuffre Randall Michael Director | 2026-06-03 17:28:29 | 40,412 0 | 40,412 | Form 4 |
| 23 | Gilman Sydney A. VP, Regulatory Affairs | 2021-07-29 21:18:27 | 25,000 0 | 25,000 | Form 4 |
| 24 | Cundari Dominic R Chief Commercial Officer | 2024-06-03 16:58:49 | 17,800 0 | 17,800 | Form 4 |